188 related articles for article (PubMed ID: 27023728)
1. Multiple myeloma cells modify VEGF/IL-6 levels and osteogenic potential of bone marrow stromal cells via Notch/miR-223.
Berenstein R; Nogai A; Waechter M; Blau O; Kuehnel A; Schmidt-Hieber M; Kunitz A; Pezzutto A; Dörken B; Blau IW
Mol Carcinog; 2016 Dec; 55(12):1927-1939. PubMed ID: 27023728
[TBL] [Abstract][Full Text] [Related]
2. Multiple myeloma-derived Jagged ligands increases autocrine and paracrine interleukin-6 expression in bone marrow niche.
Colombo M; Galletti S; Bulfamante G; Falleni M; Tosi D; Todoerti K; Lazzari E; Crews LA; Jamieson CH; Ravaioli S; Baccianti F; Garavelli S; Platonova N; Neri A; Chiaramonte R
Oncotarget; 2016 Aug; 7(35):56013-56029. PubMed ID: 27463014
[TBL] [Abstract][Full Text] [Related]
3. Multiple myeloma cells alter the senescence phenotype of bone marrow mesenchymal stromal cells under participation of the DLK1-DIO3 genomic region.
Berenstein R; Blau O; Nogai A; Waechter M; Slonova E; Schmidt-Hieber M; Kunitz A; Pezzutto A; Doerken B; Blau IW
BMC Cancer; 2015 Feb; 15():68. PubMed ID: 25886144
[TBL] [Abstract][Full Text] [Related]
4. Induction of miR-146a by multiple myeloma cells in mesenchymal stromal cells stimulates their pro-tumoral activity.
De Veirman K; Wang J; Xu S; Leleu X; Himpe E; Maes K; De Bruyne E; Van Valckenborgh E; Vanderkerken K; Menu E; Van Riet I
Cancer Lett; 2016 Jul; 377(1):17-24. PubMed ID: 27102001
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-21 promotes osteogenesis of bone marrow mesenchymal stem cells via the Smad7-Smad1/5/8-Runx2 pathway.
Li X; Guo L; Liu Y; Su Y; Xie Y; Du J; Zhou J; Ding G; Wang H; Bai Y; Liu Y
Biochem Biophys Res Commun; 2017 Nov; 493(2):928-933. PubMed ID: 28943430
[TBL] [Abstract][Full Text] [Related]
6. Impaired osteogenic differentiation of mesenchymal stem cells derived from multiple myeloma patients is associated with a blockade in the deactivation of the Notch signaling pathway.
Xu S; Evans H; Buckle C; De Veirman K; Hu J; Xu D; Menu E; De Becker A; Vande Broek I; Leleu X; Camp BV; Croucher P; Vanderkerken K; Van Riet I
Leukemia; 2012 Dec; 26(12):2546-9. PubMed ID: 22652628
[No Abstract] [Full Text] [Related]
7. Skeletrophin, a novel ubiquitin ligase to the intracellular region of Jagged-2, is aberrantly expressed in multiple myeloma.
Takeuchi T; Adachi Y; Ohtsuki Y
Am J Pathol; 2005 Jun; 166(6):1817-26. PubMed ID: 15920166
[TBL] [Abstract][Full Text] [Related]
8. Multiple myeloma cells promote migration of bone marrow mesenchymal stem cells by altering their translation initiation.
Dabbah M; Attar-Schneider O; Zismanov V; Tartakover Matalon S; Lishner M; Drucker L
J Leukoc Biol; 2016 Oct; 100(4):761-770. PubMed ID: 27272311
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of the NOTCH ligand JAG2 in malignant plasma cells from multiple myeloma patients and cell lines.
Houde C; Li Y; Song L; Barton K; Zhang Q; Godwin J; Nand S; Toor A; Alkan S; Smadja NV; Avet-Loiseau H; Lima CS; Miele L; Coignet LJ
Blood; 2004 Dec; 104(12):3697-704. PubMed ID: 15292061
[TBL] [Abstract][Full Text] [Related]
10. Bone marrow fibroblasts overexpress miR-27b and miR-214 in step with multiple myeloma progression, dependent on tumour cell-derived exosomes.
Frassanito MA; Desantis V; Di Marzo L; Craparotta I; Beltrame L; Marchini S; Annese T; Visino F; Arciuli M; Saltarella I; Lamanuzzi A; Solimando AG; Nico B; De Angelis M; Racanelli V; Mariggiò MA; Chiacchio R; Pizzuti M; Gallone A; Fumarulo R; D'Incalci M; Vacca A
J Pathol; 2019 Feb; 247(2):241-253. PubMed ID: 30357841
[TBL] [Abstract][Full Text] [Related]
11. Notch-Hes pathway mediates the impaired osteogenic differentiation of bone marrow mesenchymal stromal cells from myelodysplastic syndromes patients through the down-regulation of Runx2.
Fei C; Guo J; Zhao Y; Gu S; Zhao S; Li X; Chang C
Am J Transl Res; 2015; 7(10):1939-51. PubMed ID: 26692937
[TBL] [Abstract][Full Text] [Related]
12. Homotypic and Heterotypic Activation of the Notch Pathway in Multiple Myeloma-Enhanced Angiogenesis: A Novel Therapeutic Target?
Saltarella I; Frassanito MA; Lamanuzzi A; Brevi A; Leone P; Desantis V; Di Marzo L; Bellone M; Derudas D; Ribatti D; Chiaramonte R; Palano MT; Neri A; Mariggiò MA; Fumarulo R; Dammacco F; Racanelli V; Vacca A; Ria R
Neoplasia; 2019 Jan; 21(1):93-105. PubMed ID: 30529074
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of microRNA-138 enhances bone formation in multiple myeloma bone marrow niche.
Tsukamoto S; Løvendorf MB; Park J; Salem KZ; Reagan MR; Manier S; Zavidij O; Rahmat M; Huynh D; Takagi S; Kawano Y; Kokubun K; Thrue CA; Nagano K; Petri A; Roccaro AM; Capelletti M; Baron R; Kauppinen S; Ghobrial IM
Leukemia; 2018 Aug; 32(8):1739-1750. PubMed ID: 29925904
[TBL] [Abstract][Full Text] [Related]
14. MiR-15a/16 regulates the growth of myeloma cells, angiogenesis and antitumor immunity by inhibiting Bcl-2, VEGF-A and IL-17 expression in multiple myeloma.
Li Y; Zhang B; Li W; Wang L; Yan Z; Li H; Yao Y; Yao R; Xu K; Li Z
Leuk Res; 2016 Oct; 49():73-9. PubMed ID: 27596960
[TBL] [Abstract][Full Text] [Related]
15. Angiogenic/osteogenic response of BMMSCs on bone-derived scaffold: effect of hypoxia and role of PI3K/Akt-mediated VEGF-VEGFR pathway.
Zhou Y; Guan X; Yu M; Wang X; Zhu W; Wang C; Yu M; Wang H
Biotechnol J; 2014 Jul; 9(7):944-53. PubMed ID: 24421279
[TBL] [Abstract][Full Text] [Related]
16. Dicer1 downregulation by multiple myeloma cells promotes the senescence and tumor-supporting capacity and decreases the differentiation potential of mesenchymal stem cells.
Guo J; Zhao Y; Fei C; Zhao S; Zheng Q; Su J; Wu D; Li X; Chang C
Cell Death Dis; 2018 May; 9(5):512. PubMed ID: 29724992
[TBL] [Abstract][Full Text] [Related]
17. Long non-coding RNA BDNF-AS modulates osteogenic differentiation of bone marrow-derived mesenchymal stem cells.
Feng X; Lin T; Liu X; Yang C; Yang S; Fu D
Mol Cell Biochem; 2018 Aug; 445(1-2):59-65. PubMed ID: 29247276
[TBL] [Abstract][Full Text] [Related]
18. miR-186 inhibits cell proliferation in multiple myeloma by repressing Jagged1.
Liu Z; Zhang G; Yu W; Gao N; Peng J
Biochem Biophys Res Commun; 2016 Jan; 469(3):692-7. PubMed ID: 26679605
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of miR-21 restores RANKL/OPG ratio in multiple myeloma-derived bone marrow stromal cells and impairs the resorbing activity of mature osteoclasts.
Pitari MR; Rossi M; Amodio N; Botta C; Morelli E; Federico C; Gullà A; Caracciolo D; Di Martino MT; Arbitrio M; Giordano A; Tagliaferri P; Tassone P
Oncotarget; 2015 Sep; 6(29):27343-58. PubMed ID: 26160841
[TBL] [Abstract][Full Text] [Related]
20. miR-15a and miR-16 affect the angiogenesis of multiple myeloma by targeting VEGF.
Sun CY; She XM; Qin Y; Chu ZB; Chen L; Ai LS; Zhang L; Hu Y
Carcinogenesis; 2013 Feb; 34(2):426-35. PubMed ID: 23104180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
